ORIGINAL ARTICLE

The correlation between caspase-9 and caspase-3 on sepsis case: an experimental study on the Balb/C Mice induced by lipopolysaccharide

Sotianingsih Haryanto , Suharyo Hadisanputro, Lisyani Budipardigdo Suromo

Sotianingsih Haryanto
Department of Clinical Pathology, Raden Mattaher Hospital/ Faculty of Medicine and Health Science, University of Jambi, Jambi, Indonesia. Email: sotianingsih@yahoo.com

Suharyo Hadisanputro
Postgraduate Program of Diponegoro University, Semarang, Indonesia

Lisyani Budipardigdo Suromo
Clinical Pathology Department, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
Online First: August 01, 2019 | Cite this Article
Haryanto, S., Hadisanputro, S., Suromo, L. 2019. The correlation between caspase-9 and caspase-3 on sepsis case: an experimental study on the Balb/C Mice induced by lipopolysaccharide. Bali Medical Journal 8(2). DOI:10.15562/bmj.v8i2.1347


Introduction: Sepsis mortality rate in Indonesia reaches over 50 %, hence, acknowledgement of its pathophysiology need to be elucidated, including the pathway of apoptotic. The objective of this study was to describe the lipopolysaccharide (LPS)-induced sepsis in which triggers intrinsic apoptotic pathways in terms of the expression of caspase-9 (Cas9) and caspase-3 (Cas3).

Method: By experimental with time series randomized post test-only control group design, 48 Balb/C mice divided into 2 groups (control and treatment). Each group was injected intra-peritoneally with saline 250 µL/mice and saline 250 µL + 0.1 mg E. coli LPS/mice. Each group divided into 4 termination time (12th, 24th, 36th and 48th hours), examined by immunohistochemistry (IHC) for Cas9 and Cas3 expression, and analyzed by mean difference test (Mann-Whitney and t test) and correlation test (Spearman’s test).

Results: The LPS-induced sepsis in the treatment group revealed increasing number of caspase-9 compared to control group (2.34+0.24 vs 0.82+0.08; p<0.001. There were increasing trends in the treatment group compared to control group includes for: all groups Cas3 (1.54+0.10 vs 0.48+0.05; p<0.001), t12 Cas3 (3.25+0.22 vs 0.50+0.06; p<0.001), t24 Cas3 (1.37+0.27 vs 0.45+0.05; p=0,002), and t36 Cas3 (1.03+0.20 vs 0.52+0.22; p=0,002). Instead, there were no difference between treatment group and control group for t48 Cas3 (0.50+0.14 vs 0.43+0.10; p=0,485). There was decreasing pattern on serial time 12, 24, 36 and 48 hours for Cas9 (p<0,001) and Cas3 (p=0,002). There was a correlation between Cas9-Cas3 (rs=0.835;p=0.001).

Conclusion: The LPS-induced sepsis caused an increase of caspase-9 and caspase-3, strongly correlated with decreasing pattern on time serial.

References

Guntur HA. SIRS, Sepsis and Syok Septic (Imunologi, diagnosis, penatalaksanaan). UNS Press, Surakarta. 2006:37-48.

Rudiger A, Stotz M, Singer M. Cellular processes in sepsis (peer reviewed article). Swiss Med Wkly. 2008;148 (43-44):629-634.

Peters K, Unger RE, Brunner J, Kirkpatrick CJ. Molecular basis of endotelial dysfunction in sepsis (Review). J Cardiovascular Re. 2003;60:49-57.

Rudkowski JC, Barreiro E, Harfouche R, Goldberg P, Kishta O, D’Orleans-Juste P., et al. Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am J Physiol Lung Cell Mol Physiol. 2004;l(286):L793-800.

Oberholzer C, Obelholzer A, Clare-Salzler M, Moldawer LL. Apoptosis in sepsis: a new target for therapeutic exploration. FAESB J. 2001;l(15):879-892.

Ayala A, Wesche-Soldato DE, Perl M, Lomas-Neira JL, Swan R, Chung C. Blockade of apoptosis as a rational therapeutic strategy for the treatment of sepsis. Novartis Found Symp. 2007;280:37-164.

Hotchiss RS and Nicholson DW. Apoptosis and caspase regulate death and inflammation in sepsis. Nat Rev Imm. 2006;6:813-822.

Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES., et al. Cytochrome c and dATP-dependent formation of apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91:479-489.

Sotianingsih, Suharyo, Lisyani S, Guntur HA. Clinical manifestation sepsis and the level of NO in sepsis Balb/C mice induced by lipopolysaccharide. IJCP. 2013;19(2):65-68.

Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol. 2013;93:329–342.

Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24:1125–1128.

Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol. 2000;1:496–501.

Taneja R, Parodo J, Jia SH, Kapus A, Rotstein OD, Marshall JC. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med. 2004; 32(7):1460-9.

Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol. 2008;294:L632–L641.

Hotchkiss RS, Coopersmith CM, Karl IE. Prevention of lymphocyte apoptosis - a potential treatment of sepsis? Clin Infect Dis. 2005;41:S465–S469.


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0